Using a single inhaler device containing an inhaled corticosteroid plus a long-acting β-adrenoceptor agonist is a practical approach in patients with moderate to severe asthma

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2008年 / 24卷 / 3期
关键词：
Asthma; Salmeterol; Formoterol; Nedocromil; Zafirlukast;
D O I：
10.2165/00042310-200824030-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：2
相关论文
共 50 条
  • [31] Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study
    Wang, Yan
    Chen, Ping
    Dai, Anna
    Shang, Shengyun
    Kong, Lingfei
    CLINICAL THERAPEUTICS, 2016, 38 (12) : 2622 - 2627
  • [32] Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Price, David
    Bousquet, Jean
    RESPIRATORY MEDICINE, 2012, 106 : S4 - S8
  • [33] Combination therapy with a long-acting β2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma -: Response
    Murray, J
    Dorinsky, P
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (03) : 411 - 412
  • [34] A Single Inhaler Combining a Corticosteroid and Long-Acting Beta-2 Agonist for Maintenance with Additional Doses for Reliever Therapy (SMART): Obstacles for Asthma Patients in the USA
    Hendeles, Leslie
    Blake, Kathryn, V
    Galbreath, Ashley
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2021, 34 (02) : 73 - 75
  • [35] CAPTAIN: Effects of Adding the Long-Acting Muscarinic Antagonist Umeclidinium to Inhaled Corticosteroid/Long-Acting Beta2-Agonist Therapy on Symptoms in Patients with Inadequately Controlled Asthma
    Gardiner, F.
    Pizzichini, E.
    Pavord, I
    Brusselle, G.
    Oppenheimer, J.
    Kerstjens, H.
    Papi, A.
    Inoue, H.
    Tabberer, M.
    Fowler, A.
    Slade, D.
    Bailes, Z.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [36] Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
    Yang, Hsi-Hsing
    Lai, Chih-Cheng
    Wang, Ya-Hui
    Yang, Wei-Chih
    Wang, Cheng-Yi
    Wang, Hao-Chien
    Chen, Likwang
    Yu, Chong-Jen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2477 - 2484
  • [37] Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease
    Nannini, L. J.
    Cates, C. J.
    Lasserson, T. J.
    Poole, P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
  • [38] Lifetime Benefits for Budesonide/Glycopyrrolate/Formoterol Fumarate versus Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist and Inhaled Corticosteroid/Long-Acting β2-Agonist Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
    De Nigris, E.
    Treharne, C.
    Brighton, N.
    Holmgren, U.
    Walker, A.
    Haughney, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] CLINICAL AND ECONOMIC BURDEN OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UK: IMPACT OF CRITICAL INHALER ERRORS WITH INHALED CORTICOSTEROID plus LONG-ACTING BETA AGONIST FIXED-DOSE COMBINATIONS
    Lewis, A.
    Blackney, M.
    Torvinen, S.
    Plich, A.
    VALUE IN HEALTH, 2014, 17 (03) : A174 - A174
  • [40] Comparison Of Inhaled Corticosteroid Monotherapy And Long Acting 2-Agonist/Inhaled Corticosteroid Combination Therapy In Patients With Cough Variant Asthma
    Miyazawa, N.
    Sato, T.
    Hayashi, M.
    Yamamoto, M.
    Tomaru, K.
    Tsukahara, T.
    Takahashi, R.
    Sasaki, M.
    Kaneko, T.
    Ishigatsubo, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
12345